|
시장보고서
상품코드
1967812
세포치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Cell Therapy Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
세포치료 시장 규모는 2025년 3,058만 달러에서 2034년에는 1억 5,242만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 19.54%로 성장할 전망입니다.
재생의료와 면역치료의 획기적인 발전으로 세계 세포치료제 시장은 빠르게 성장하고 있습니다. 암, 자가면역질환, 유전성 질환의 치료에 세포 기반 치료법이 점점 더 많이 활용되고 있습니다. 임상 연구의 확대와 규제 당국의 승인으로 헬스케어 시스템 전반에 걸쳐 상업적 도입이 강화되고 있습니다.
성장 요인으로는 만성질환 증가, 줄기세포 연구의 발전, 생명공학 분야에 대한 투자 확대 등을 꼽을 수 있습니다. CAR-T 치료와 개인맞춤형 치료 접근법은 암 치료의 방식을 바꾸고 있습니다. 그러나 높은 치료 비용과 제조 공정의 복잡성은 보급을 위한 주요 과제로 남아있습니다.
향후 전망으로는 확장 가능한 제조 기술의 기술 혁신과 규제 프로세스 개선이 시장 성장을 가속화할 것으로 보입니다. 생명공학 기업과 의료 제공자 간의 전략적 제휴를 통해 전 세계에서 보급이 확대될 것으로 예측됩니다. 세포치료 분야는 지속적인 연구 진행과 함께 큰 폭의 확장을 앞두고 있습니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 세포치료 시장 : 기술별
제5장 세계의 세포치료 시장 : 유형별
제6장 세계의 세포치료 시장 : 세포 유형별
제7장 세계의 세포치료 시장 : 세포원별
제8장 세계의 세포치료 시장 : 용도별
제9장 세계의 세포치료 시장 : 최종사용자별
제10장 세계의 세포치료 시장 : 지역별
제11장 경쟁 구도
제12장 기업 개요
KSA 26.03.24The Cell Therapy Market size is expected to reach USD 152.42 Million in 2034 from USD 30.58 Million (2025) growing at a CAGR of 19.54% during 2026-2034.
The global cell therapy market is growing rapidly due to breakthroughs in regenerative medicine and immunotherapy. Cell-based treatments are increasingly used to address cancer, autoimmune diseases, and genetic disorders. Expanding clinical research and regulatory approvals are strengthening commercial adoption across healthcare systems.
Growth drivers include rising prevalence of chronic diseases, advancements in stem cell research, and increasing investment in biotechnology. CAR-T therapies and personalized treatment approaches are transforming oncology care. However, high treatment costs and complex manufacturing processes remain key challenges for widespread accessibility.
Looking forward, technological innovation in scalable manufacturing and improved regulatory pathways will accelerate market growth. Strategic collaborations between biotech firms and healthcare providers are expected to expand global availability. The cell therapy sector is poised for substantial expansion as research continues to advance.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Viral Vector Technology
- Genome Editing Technology
- Cell Plasticity Technology
- Three-Dimensional Technology
By Type
- Autologous
- Allogeneic
By Cell Type
- Stem Cell
- Non-Stem Cell
By Cell Source
- Induced Pluripotent Stem Cells
- Bone Marrow
- Umbilical Cord Blood-Derived Cells
- Adipose Tissues
- Neural Stem Cells
By Application
- Musculoskeletal
- Cardiovascular
- Gastrointestinal
- Neurological
- Oncology
- Dermatology
- Wounds and Injuries
- Ocular
- Others
By End-User
- Hospitals and Clinics
- Regenerative Medicine Centres
- Diagnostic and Research Centres
- Others
COMPANIES PROFILED
- Kolon TissueGene Inc, JCR Pharmaceuticals Co Ltd, Medipost, Stemedica Cell Technologies Inc, NuVasive Inc, Castle Creek Biosciences Inc, Cellectis, BioNTech IMFS, Pluri Biotech Ltd, Praxis Healthcare Pharmaceuticals PVT LTD, Pharmicell Co Ltd
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL CELL THERAPY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Technology
- 4.2. Somatic Cell Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Cell Immortalization Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Viral Vector Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Genome Editing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.6. Cell Plasticity Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.7. Three-Dimensional Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL CELL THERAPY MARKET: BY TYPE 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Type
- 5.2. Autologous Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Allogeneic Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL CELL THERAPY MARKET: BY CELL TYPE 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Cell Type
- 6.2. Stem Cell Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Non-Stem Cell Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL CELL THERAPY MARKET: BY CELL SOURCE 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast Cell Source
- 7.2. Induced Pluripotent Stem Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Bone Marrow Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Umbilical Cord Blood-Derived Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Adipose Tissues Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.6. Neural Stem Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL CELL THERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)
- 8.1. Market Analysis, Insights and Forecast Application
- 8.2. Musculoskeletal Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.3. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.4. Gastrointestinal Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.5. Neurological Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.6. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.7. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.8. Wounds and Injuries Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.9. Ocular Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 9. GLOBAL CELL THERAPY MARKET: BY END-USER 2022-2034 (USD MN)
- 9.1. Market Analysis, Insights and Forecast End-user
- 9.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 9.3. Regenerative Medicine Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 9.4. Diagnostic and Research Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 9.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 10. GLOBAL CELL THERAPY MARKET: BY REGION 2022-2034(USD MN)
- 10.1. Regional Outlook
- 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.2.1 By Technology
- 10.2.2 By Type
- 10.2.3 By Cell Type
- 10.2.4 By Cell Source
- 10.2.5 By Application
- 10.2.6 By End-user
- 10.2.7 United States
- 10.2.8 Canada
- 10.2.9 Mexico
- 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.3.1 By Technology
- 10.3.2 By Type
- 10.3.3 By Cell Type
- 10.3.4 By Cell Source
- 10.3.5 By Application
- 10.3.6 By End-user
- 10.3.7 United Kingdom
- 10.3.8 France
- 10.3.9 Germany
- 10.3.10 Italy
- 10.3.11 Russia
- 10.3.12 Rest Of Europe
- 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.4.1 By Technology
- 10.4.2 By Type
- 10.4.3 By Cell Type
- 10.4.4 By Cell Source
- 10.4.5 By Application
- 10.4.6 By End-user
- 10.4.7 India
- 10.4.8 Japan
- 10.4.9 South Korea
- 10.4.10 Australia
- 10.4.11 South East Asia
- 10.4.12 Rest Of Asia Pacific
- 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.5.1 By Technology
- 10.5.2 By Type
- 10.5.3 By Cell Type
- 10.5.4 By Cell Source
- 10.5.5 By Application
- 10.5.6 By End-user
- 10.5.7 Brazil
- 10.5.8 Argentina
- 10.5.9 Peru
- 10.5.10 Chile
- 10.5.11 South East Asia
- 10.5.12 Rest of Latin America
- 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 10.6.1 By Technology
- 10.6.2 By Type
- 10.6.3 By Cell Type
- 10.6.4 By Cell Source
- 10.6.5 By Application
- 10.6.6 By End-user
- 10.6.7 Saudi Arabia
- 10.6.8 UAE
- 10.6.9 Israel
- 10.6.10 South Africa
- 10.6.11 Rest of the Middle East And Africa
Chapter 11. COMPETITIVE LANDSCAPE
- 11.1. Recent Developments
- 11.2. Company Categorization
- 11.3. Supply Chain & Channel Partners (based on availability)
- 11.4. Market Share & Positioning Analysis (based on availability)
- 11.5. Vendor Landscape (based on availability)
- 11.6. Strategy Mapping
Chapter 12. COMPANY PROFILES OF GLOBAL CELL THERAPY INDUSTRY
- 12.1. Top Companies Market Share Analysis
- 12.2. Company Profiles
- 12.2.1 Kolon TissueGene Inc
- 12.2.2 JCR Pharmaceuticals Co. Ltd
- 12.2.3 Medipost
- 12.2.4 Stemedica Cell Technologies Inc
- 12.2.5 NuVasive Inc
- 12.2.6 Castle Creek Biosciences Inc
- 12.2.7 Cellectis
- 12.2.8 BioNTech IMFS
- 12.2.9 Pluri Biotech Ltd
- 12.2.10 Praxis Healthcare & Pharmaceuticals PVT. LTD
- 12.2.11 Pharmicell Co. Ltd
